AU2003999A - Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof - Google Patents

Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof

Info

Publication number
AU2003999A
AU2003999A AU20039/99A AU2003999A AU2003999A AU 2003999 A AU2003999 A AU 2003999A AU 20039/99 A AU20039/99 A AU 20039/99A AU 2003999 A AU2003999 A AU 2003999A AU 2003999 A AU2003999 A AU 2003999A
Authority
AU
Australia
Prior art keywords
dioxobenzothiazoles
analogues
modulators
aryl
ryanodine receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20039/99A
Inventor
Henry R. Besch Jr.
Keshore R. Bidasee
Yvette A. Jackson
Michael A. Lyon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of the West Indies
Indiana University Research and Technology Corp
Original Assignee
University of the West Indies
Indiana University Research and Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of the West Indies, Indiana University Research and Technology Corp filed Critical University of the West Indies
Publication of AU2003999A publication Critical patent/AU2003999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU20039/99A 1997-12-19 1998-12-18 Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof Abandoned AU2003999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7179197P 1997-12-19 1997-12-19
US60071791 1997-12-19
PCT/US1998/027002 WO1999032115A1 (en) 1997-12-19 1998-12-18 Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof

Publications (1)

Publication Number Publication Date
AU2003999A true AU2003999A (en) 1999-07-12

Family

ID=22103628

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20039/99A Abandoned AU2003999A (en) 1997-12-19 1998-12-18 Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof

Country Status (2)

Country Link
AU (1) AU2003999A (en)
WO (1) WO1999032115A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074810A2 (en) * 2000-03-31 2001-10-11 Ortho Mcneil Pharmaceutical, Inc. Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
WO2001074815A2 (en) 2000-03-31 2001-10-11 Ortho Mcneil Pharmaceutical, Inc. Phenyl-substituted imidazopyridines
AU2000272704A1 (en) * 2000-09-15 2002-03-26 Boehringer Ingelheim International G.M.B.H Use of compounds for the treatment of obesity
ATE368654T1 (en) * 2001-12-27 2007-08-15 Sod Conseils Rech Applic BENZOTHIAZOLE AND BENZOXAZOLE-4,7-DIONE DERIVATIVES AND THEIR USE AS CDC25 PHOSPHATASE INHIBITORS
AR045362A1 (en) * 2003-08-18 2005-10-26 Solvay Pharm Bv STABLE CRYSTALLINE FORM OF BIFEPRUNOX MESILATE (MONOMETANSULFONATE 7- [4 - ([1,1- BIFENIL] -3- ILMETIL) -1- PIPERAZINIL] - 2- (3H) -BENZOXAZOLONA
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742153B1 (en) * 1995-12-12 1998-02-13 Innothera Lab Sa USE OF TRICYCLIC DERIVATIVES OF 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTALENE, NEW COMPOUNDS OBTAINED AND THEIR THERAPEUTIC APPLICATION
FR2742155B1 (en) * 1995-12-12 1998-02-13 Innothera Lab Sa USE OF HETEROAROMATIC AND TRICYCLIC DERIVATIVES OF 1,4-DIHYDRO-1,4-DIOXONAPHTALENE, NOVEL COMPOUNDS OBTAINED AND THEIR APPLICATION IN THERAPEUTICS

Also Published As

Publication number Publication date
WO1999032115A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
GB2321114B (en) An optical modulator
AUPO889497A0 (en) An applicator
AU8823098A (en) Coated manicure implement
AU1242399A (en) Nose sprayer
AU5182999A (en) Electro optic modulator
GB9922840D0 (en) An optical modulator
AU7595898A (en) Single mode laser
AU6928098A (en) Optical modulator
AU4883797A (en) Self-injection device
AUPO742497A0 (en) An applicator
AU5786498A (en) Optical device
AU7132898A (en) Edg-1-like receptor
AU7333398A (en) Nasal melatonin composition
AU6394998A (en) Oxazolidines as 5-ht2a-antagonists
AU1535699A (en) Novel receptors opg-2
AU1334799A (en) Novel cytokine receptors
AU2003999A (en) Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof
AU1410801A (en) Variants of alternative splicing
AU6641698A (en) Optical device
GB2321115B (en) Operation of optical modulators
AU9432598A (en) Optical flowmeter
AU5533898A (en) Cork-based protected stopper
AU6105998A (en) Optical device
AU6134298A (en) Conformable structures
AU4203897A (en) Dental bridge

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase